Latest filing published 05 Oct 2026 for PROCTER & GAMBLE Co.
Moses Victor Javier Aguilar heads research and development at Procter & Gamble (filed title: Chf Rsch, Dev & Innov Officer) and has 32 filings between December 17, 2020 and October 5, 2026. Activity picked up: 9 filings in 2021, then 5 or 6 a year since 2024.
The record holds 9 sales worth EUR 5.6 million, with a median of EUR 375,732. The largest is dated February 13, 2026 (EUR 2,074,078). Next come May 5, 2025 (EUR 1,475,423) and August 20, 2024 (EUR 937,189). There are also 8 option exercises and 15 share grants, and no purchase.
Over the last twelve months, 7 filings are recorded, 3 of them sales. They are published a median of 2 days after the trade, across 32 dated filings.
5, 5 and 5 trades by Aguilar fall within 30 days of colleagues at PROCTER & GAMBLE Co, in that order, every one in the same direction. The colleagues, in the same order: Andre Schulten, Jon R. Moeller and Marc S. Pritchard.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 40 declarations